COVID-19
Conditions
Interventions
treatment group:usual care+Xuanfeizhisou Mixture
control group:usual care
Sponsors
Shuguang Hospital Affiliated to Shanghai University of T.C.M.
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Patients with mild and moderate novel coronavirus pneumonia confirmed in accordance with the Diagnosis and Treatment Plan for Novel Coronavirus Pneumonia (Trial Version 9th); (2) TCM syndrome differentiation is wind evil and lung syndrome; (3) Two points for cough symptoms score; (4) Age is over 18-75 years old, with no limit on gender.
Exclusion criteria
Exclusion criteria: (1) Patients with severe pneumonia requiring mechanical ventilation and critical novel coronavirus pneumonia; (2) Those who are expected to die within 48 hours; (3) Respiratory tract infections caused by primary immune deficiency disease, acquired immune deficiency syndrome, congenital respiratory malformations, congenital heart disease, lung development abnormalities and other basic diseases; (4) Chest CT confirmed the existence of serious lung interstitial lesions and other underlying lung diseases; (5) According by the researchers, previous or current diseases may affect the outcome of patient trials or research, including malignant diseases, autoimmune diseases, severe malnutrition, etc.; and diseases that seriously affect the immune system, such as human immunodeficiency virus (HIV) infection, or blood system, or splenectomy, organ transplantation, etc. (6) Women during pregnancy and lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cough index; | — |
Secondary
| Measure | Time frame |
|---|---|
| cough disappear rate at the 7th day;time of cough diappear day;TCM symdrome efficacy;cough VAS score;cough relieve time; | — |
Countries
China
Contacts
Public ContactWei Zhang
Outcome results
None listed